- Home
- BOTJ vs PRLD Comparison
BOTJ vs PRLD Comparison
Compare BOTJ & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOTJ
- PRLD
- Stock Information
- Founded
- BOTJ 1998
- PRLD 2016
- Country
- BOTJ United States
- PRLD United States
- Employees
- BOTJ N/A
- PRLD N/A
- Industry
- BOTJ Major Banks
- PRLD Medicinal Chemicals and Botanical Products
- Sector
- BOTJ Finance
- PRLD Health Care
- Exchange
- BOTJ Nasdaq
- PRLD Nasdaq
- Market Cap
- BOTJ 60.2M
- PRLD 53.4M
- IPO Year
- BOTJ N/A
- PRLD 2020
- Fundamental
- Price
- BOTJ $14.60
- PRLD $0.95
- Analyst Decision
- BOTJ
- PRLD Buy
- Analyst Count
- BOTJ 0
- PRLD 3
- Target Price
- BOTJ N/A
- PRLD $5.33
- AVG Volume (30 Days)
- BOTJ 6.4K
- PRLD 405.0K
- Earning Date
- BOTJ 10-25-2024
- PRLD 11-06-2024
- Dividend Yield
- BOTJ 2.71%
- PRLD N/A
- EPS Growth
- BOTJ N/A
- PRLD N/A
- EPS
- BOTJ 1.86
- PRLD N/A
- Revenue
- BOTJ $43,923,000.00
- PRLD $3,000,000.00
- Revenue This Year
- BOTJ N/A
- PRLD N/A
- Revenue Next Year
- BOTJ N/A
- PRLD N/A
- P/E Ratio
- BOTJ $7.95
- PRLD N/A
- Revenue Growth
- BOTJ 1.36
- PRLD N/A
- 52 Week Low
- BOTJ $9.65
- PRLD $0.93
- 52 Week High
- BOTJ $15.75
- PRLD $6.80
- Technical
- Relative Strength Index (RSI)
- BOTJ 68.12
- PRLD 21.23
- Support Level
- BOTJ $14.01
- PRLD $0.93
- Resistance Level
- BOTJ $14.58
- PRLD $1.36
- Average True Range (ATR)
- BOTJ 0.40
- PRLD 0.09
- MACD
- BOTJ 0.09
- PRLD 0.03
- Stochastic Oscillator
- BOTJ 100.00
- PRLD 4.13
About BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments, community banking; mortgage banking, and investment advisory services.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.